Studies have shown that people with high levels of omega-3s are better protected against serious COVID-19 infections.

Published Date: 02 Mar 2023

A study recently published in the American Journal of Clinical Nutrition (AJCN) investigated the role of omega-3 fatty acids, specifically EPA and DHA, and whether they can prevent poor and/or negative weight loss. .

Read Full News

Latest News

US Military No Longer Required to Get Flu Vaccine, Hegseth Says

The Pentagon will no longer require members of the U.S. military to get the ⁠flu vaccine, Defense Secretary Pete Hegseth said on Tuesday.

The Long-COVID Crisis: No Cure, Little Attention

On International Long COVID Awareness Day, advocates warned that long COVID — affecting 400 million people — remains underrecognized by clinicians and underfunded.

Moderna Starts Late-stage Trial of Bird Flu Vaccine in US, UK

Moderna said on Tuesday it had started a late-stage study of its experimental bird flu vaccine ⁠in the U.S. and the UK, marking the first time a pandemic bird flu vaccine...

Long COVID May Persist as Diagnostic Gaps Remain

Long COVID reflects persistent biological dysfunction with multisystem involvement, while gaps in biomarkers and treatment continue to complicate diagnosis and clinical care.

US CDC Will Not Publish Report Showing COVID Vaccine Effectiveness

A report showing the efficacy of COVID-19 vaccines has been blocked from being published in the U.S. ⁠Centers for Disease Control and Prevention's flagship scientific...

Deadly Meningitis Spreads as Sudanese Refugees Pack Chad Camps, MSF Says

Cases of deadly meningitis are surging in eastern Chad, killing ⁠nearly 12% of children who catch it in an area housing hundreds of thousands of ⁠war refugees from...

Todays Updates

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

Todays Updates

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

Latest News

The Pentagon will no longer require members of the U.S. military to get the ⁠flu vaccine, Defense Secretary Pete Hegseth said on Tuesday.

On International Long COVID Awareness Day, advocates warned that long COVID — affecting 400 million people — remains underrecognized by clinicians and underfunded.

Moderna said on Tuesday it had started a late-stage study of its experimental bird flu vaccine ⁠in the U.S. and the UK, marking the first time a pandemic bird flu vaccine...

Long COVID reflects persistent biological dysfunction with multisystem involvement, while gaps in biomarkers and treatment continue to complicate diagnosis and clinical care.

A report showing the efficacy of COVID-19 vaccines has been blocked from being published in the U.S. ⁠Centers for Disease Control and Prevention's flagship scientific...

Cases of deadly meningitis are surging in eastern Chad, killing ⁠nearly 12% of children who catch it in an area housing hundreds of thousands of ⁠war refugees from...

News All Time

US FDA Approves Waters' At‑home Cervical Cancer Screening Kit

Lab equipment maker Waters said on Wednesday the U.S. Food and Drug ⁠Administration has cleared its at-home cervical cancer screening kit for use with an ⁠approved HPV test,...

On-Site Hepatitis C Care Boosts Treatment Uptake

On-site hepatitis C virus testing and treatment with peer support at opioid treatment programs boosts access to curative therapy and sharply increases treatment initiation.

Fungal Extract May Improve COVID Vaccine Response

Researchers report that fungal extracts may influence vaccine reactogenicity and antibody kinetics, with effects observed only in individuals without prior SARS-CoV-2 exposure.

Can Severe Infections Raise Your Dementia Risk?

Severe infections such as cystitis and bacterial infection of an unspecified site may raise the risk of developing dementia, even after accounting for other illnesses.

Exclusive-US Upends Global Supply Program for Malaria and HIV Amid Warnings of Gaps

The U.S. is upending the way it delivers medical supplies for diseases such as HIV and malaria to lower-income countries, according to seven sources and an internal email,...

African Ancestry Linked to Fewer TB Adverse Events

A 10% rise in African ancestry lowered odds of moderate TB drug reactions, while a 10% increase in European ancestry raised them — implications for surveillance.

Cervical Cancer Screening Update: Why Less Is More

Cervical cancer screening has evolved. Dr Neil Skolnik delivers an update on why we now wait until age 25 to start and how self-testing is changing the pelvic exam landscape.

Exclusive-Pfizer, BioNTech Halt US COVID Vaccine Study After Recruitment Struggles

Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too...

Low CD4 Count Tied to Cervical Cancer Risk in HIV Infection

A lower CD4 count is associated with a higher risk for cervical carcinoma in situ and cervical cancer in women with HIV infection.

Does HIV Status Affect Long COVID Manifestations?

Patients with HIV infection are at a higher risk of developing long COVID manifestations than those without HIV infection.

Is Integrase Inhibitor-Based HIV Therapy Safe in Pregnancy?

In utero exposure to integrase inhibitor-based antiretroviral regimens is not associated with adverse 1-year neurodevelopmental outcomes compared with exposure to other antiretroviral regimens.

Nigerian HIV Volunteers Went Door-to-Door Amid Aid Cuts

For several months last year, Josephine Angev walked the dusty village paths of Nigeria's Benue State to help people living with HIV stay on their life-saving medication.

Ryan White: The Safety Net We Cannot Afford to Shrink

Dr Daskalakis shares the important strides that HIV/AIDS care has made and how critical access to care can be for some patients.

Kennedy Allies Petition to Broaden US Vaccine Injury List

An anti-vaccine group aligned with U.S. Health Secretary Robert F. Kennedy Jr. is petitioning him to vastly broaden a federal list to include more than 300 injuries it says...

Kids Confirmed as Top Transmitters of RSV

New modeling data support targeted prevention efforts.

Kent Meningitis Outbreak Triggers Surge in UK Vaccine Demand, Policy Debate

Young people in southeast England and beyond are lining up for the meningitis B vaccine after an outbreak killed two people, sparking supply warnings from pharmacies and...

Recommended News For You

Atezolizumab Consolidation Impresses in High-Risk DLBCL

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

Research discovery halts childhood brain tumor before it forms

unhealthy sleeping habits and the risk of esophageal adenocarcinoma.

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

Recommended Articles For You

Polycythemia Vera: A Historical Perspective and Contemporary Management 

Myeloproliferative Disorders: Causes, Symptoms and Treatment Options  

A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease 

Uncovering the Subtle Signs of Leukemia: A Guide to Early Detection 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.

2.

Study confirms link between breast density, higher breast cancer risk

3.

More pain, more gain? New biopsy technique found to improve prostate cancer detection

4.

Year in Review: Chronic Lymphocytic Leukemia

5.

New Gene Therapy Nears EU Nod for Bladder Cancer

1.

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis

2.

A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities

3.

Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions

4.

The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring

5.

Uncovering New Hope for Follicular Lymphoma Patients

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

2.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot